Altimmune Inc (ALT)
8.40
+0.35
(+4.35%)
USD |
NASDAQ |
Nov 21, 16:00
8.50
+0.10
(+1.19%)
After-Hours: 18:25
Altimmune Market Cap: 597.45M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 572.55M |
| November 19, 2024 | 531.30M |
| November 18, 2024 | 508.54M |
| November 15, 2024 | 541.26M |
| November 14, 2024 | 601.36M |
| November 13, 2024 | 677.11M |
| November 12, 2024 | 674.97M |
| November 11, 2024 | 522.77M |
| November 08, 2024 | 546.24M |
| November 07, 2024 | 530.59M |
| November 06, 2024 | 519.92M |
| November 05, 2024 | 500.00M |
| November 04, 2024 | 482.93M |
| November 01, 2024 | 479.38M |
| October 31, 2024 | 479.38M |
| October 30, 2024 | 480.80M |
| October 29, 2024 | 523.48M |
| October 28, 2024 | 498.58M |
| October 25, 2024 | 475.82M |
| October 24, 2024 | 481.16M |
| October 23, 2024 | 477.96M |
| October 22, 2024 | 483.65M |
| October 21, 2024 | 490.76M |
| October 18, 2024 | 489.34M |
| October 17, 2024 | 482.93M |
| Date | Value |
|---|---|
| October 16, 2024 | 487.91M |
| October 15, 2024 | 500.72M |
| October 14, 2024 | 457.33M |
| October 11, 2024 | 448.08M |
| October 10, 2024 | 428.17M |
| October 09, 2024 | 434.57M |
| October 08, 2024 | 443.82M |
| October 07, 2024 | 433.86M |
| October 04, 2024 | 443.10M |
| October 03, 2024 | 437.42M |
| October 02, 2024 | 445.95M |
| October 01, 2024 | 447.37M |
| September 30, 2024 | 436.70M |
| September 27, 2024 | 459.83M |
| September 26, 2024 | 483.99M |
| September 25, 2024 | 497.50M |
| September 24, 2024 | 506.03M |
| September 23, 2024 | 511.71M |
| September 20, 2024 | 553.64M |
| September 19, 2024 | 538.01M |
| September 18, 2024 | 528.06M |
| September 17, 2024 | 538.01M |
| September 16, 2024 | 538.72M |
| September 13, 2024 | 560.04M |
| September 12, 2024 | 504.60M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
24.85M
Minimum
Nov 22 2019
1.099B
Maximum
Sep 02 2022
412.18M
Average
443.48M
Median
Nov 15 2021
Market Cap Benchmarks
| Eli Lilly and Co | 711.90B |
| Viking Therapeutics Inc | 5.757B |
| Amgen Inc | 155.82B |
| Avid Bioservices Inc | 781.81M |
| NovaBay Pharmaceuticals Inc | 3.508M |
Market Cap Related Metrics
| PS Ratio | 10956.78 |
| PEG Ratio | -2.747 |
| Price to Book Value | 4.479 |
| Price | 8.40 |
| Earnings Yield | -18.69% |